Citigroup Inc Neogenomics Inc Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Citigroup Inc holds 165,308 shares of NEO stock, worth $2.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

165,308

Previous 97,166 70.13%

Holding current value

$2.31 Million

Previous $1.35 Million 80.99%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$13.4 - $17.73 $913,102 - $1.21 Million	68,142 Added 70.13%	165,308 $2.44 Million
Q2 2024 Aug 12, 2024	BUY	$13.01 - $15.77 $91,017 - $110,326	6,996 Added 7.76%	97,166 $1.35 Million
Q1 2024 May 10, 2024	BUY	$14.06 - $16.79 $118,680 - $141,724	8,441 Added 10.33%	90,170 $1.42 Million
Q4 2023 Feb 09, 2024	BUY	$11.67 - $20.73 $310,422 - $551,418	26,600 Added 48.25%	81,729 $1.32 Million
Q3 2023 Nov 09, 2023	SELL	$12.15 - $17.85 $534,733 - $785,596	-44,011 Reduced 44.39%	55,129 $678,000
Q2 2023 Aug 10, 2023	BUY	$14.1 - $19.83 $479,329 - $674,120	33,995 Added 52.18%	99,140 $1.59 Million
Q1 2023 May 11, 2023	SELL	$9.09 - $19.45 $179,318 - $383,690	-19,727 Reduced 23.24%	65,145 $1.13 Million
Q4 2022 Feb 09, 2023	BUY	$6.45 - $12.07 $125,813 - $235,437	19,506 Added 29.84%	84,872 $784,000
Q3 2022 Nov 10, 2022	SELL	$7.86 - $12.91 $2.33 Million - $3.82 Million	-296,040 Reduced 81.91%	65,366 $563,000
Q2 2022 Aug 10, 2022	SELL	$7.06 - $13.97 $62,248 - $123,173	-8,817 Reduced 2.38%	361,406 $2.95 Million
Q1 2022 May 12, 2022	BUY	$12.15 - $35.28 $3.2 Million - $9.28 Million	263,007 Added 245.31%	370,223 $4.5 Million
Q4 2021 Feb 10, 2022	BUY	$30.49 - $48.49 $259,561 - $412,795	8,513 Added 8.62%	107,216 $3.66 Million
Q3 2021 Nov 10, 2021	BUY	$41.66 - $52.52 $4.11 Million - $5.18 Million	98,703 New	98,703 $4.76 Million

Others Institutions Holding NEO

# of Institutions

292

Shares Held

124M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.76B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account